These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. Powers JL Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244 [TBL] [Abstract][Full Text] [Related]
4. The newer macrolides: azithromycin and clarithromycin. Zuckerman JM Infect Dis Clin North Am; 2000 Jun; 14(2):449-62, x. PubMed ID: 10829265 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection. Adeleye IA; Uwagboe UC West Indian Med J; 2003 Dec; 52(4):325-6. PubMed ID: 15040073 [No Abstract] [Full Text] [Related]
6. Azithromycin: an interim analysis. Ball AP J Int Med Res; 1991; 19(6):446-50. PubMed ID: 1663467 [TBL] [Abstract][Full Text] [Related]
7. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Dunn CJ; Barradell LB Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic and clinical evaluation of azithromycin in pediatrics]. Okumura A; Kuno K Jpn J Antibiot; 1996 Nov; 49(11):994-1003. PubMed ID: 8988411 [TBL] [Abstract][Full Text] [Related]
9. Introduction: revolutionary changes in the macrolide and azalide antibiotics. Moellering RC Am J Med; 1991 Sep; 91(3A):1S-4S. PubMed ID: 1656735 [No Abstract] [Full Text] [Related]
10. [Five years of sumamed on Russian market]. Sadovnikova SF; Selina EV Antibiot Khimioter; 1997; 42(11):42-4. PubMed ID: 9463300 [No Abstract] [Full Text] [Related]
11. Disk diffusion sensitivity testing and antibacterial activity of azithromycin. Davila D; Tambić T; Djokić S; Kolacny-Babić L Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164 [TBL] [Abstract][Full Text] [Related]
12. [Sumamed--efficacy and convenience]. Sirakov M; Ivanov S Akush Ginekol (Sofiia); 2005; 44 Suppl 2():38-42. PubMed ID: 16028403 [No Abstract] [Full Text] [Related]
13. [Clarithromycin: specific features of antimicrobial spectrum and clinical use]. Budanov SV; Vasil'ev AN Antibiot Khimioter; 2004; 49(2):19-25. PubMed ID: 15285409 [No Abstract] [Full Text] [Related]
14. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. Merchan LM; Hassan HE; Terrin ML; Waites KB; Kaufman DA; Ambalavanan N; Donohue P; Dulkerian SJ; Schelonka R; Magder LS; Shukla S; Eddington ND; Viscardi RM Antimicrob Agents Chemother; 2015 Jan; 59(1):570-8. PubMed ID: 25385115 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field]. Okada T; Machida Y; Fujieda M; Shimazaki Y; Kurashige T Jpn J Antibiot; 1996 Nov; 49(11):1024-9. PubMed ID: 8988414 [TBL] [Abstract][Full Text] [Related]
16. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. Roord JJ; Wolf BH; Gossens MM; Kimpen JL Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of Achillea clavennae essential oil against respiratory tract pathogens. Skocibusić M; Bezić N; Dunkić V; Radonić A Fitoterapia; 2004 Dec; 75(7-8):733-6. PubMed ID: 15567252 [TBL] [Abstract][Full Text] [Related]